Omnia SanaPlant Comparison
Flaxseed vs Fenugreek
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Flaxseed and Fenugreek: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), cardiovascular / heart health, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Flaxseed | Fenugreek | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 3/10 | 8/10 | Stronger for Fenugreek |
| Cancer (anticancer research) | 7/10 | 7/10 | Comparable evidence |
| Cardiovascular / heart health | 6/10 | 7/10 | Comparable evidence |
| Inflammation (general) | 3/10 | 7/10 | Stronger for Fenugreek |
| Metabolic support | 6/10 | 7/10 | Comparable evidence |
| Skin irritation | 3/10 | 7/10 | Stronger for Fenugreek |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Flax is the richest dietary source of SDG-type lignans, converted by gut bacteria to the mammalian lignans enterodiol and enterolactone; studied for antioxidant and hormone-modulating activity.
The dominant fatty acid of the seed oil (~50-55% of total oil), a plant-based omega-3 studied for cardiovascular and anti-inflammatory effects.
Concentrated in the seed coat; gives flaxseed its demulcent, laxative, bulk-forming action.
Present at low levels; cooking/roasting reduces them to negligible amounts in normal food use - a theoretical concern only at high raw intakes.
Thought to contribute to the antidiabetic and cholesterol-lowering effects.
Mucilaginous soluble fiber that slows carbohydrate absorption, a key mechanism behind the blood-sugar-lowering effect.
An unusual amino acid studied for insulin-potentiating activity.
Aromatic lactone responsible for fenugreek's characteristic maple-syrup smell, including the body-odor effect reported with supplementation.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Flaxseeds are safe for most people at recommended food amounts (1–2 tablespoons ground/day). They must be ground or milled to be bioavailable — whole seeds largely pass through the gut undigested. High fibre content may cause bloating, flatulence, and loose stools, especially if fibre intake is increased rapidly without adequate hydration. Flaxseeds contain cyanogenic glycosides (linamarin, linustatin); cooking or roasting reduces these to negligible levels in normal food amounts. Raw seeds in very large quantities are a theoretical concern, but typical use is safe (EFSA, 2017).
Medication interactions: Flaxseed may reduce absorption of oral medications if taken simultaneously — space flaxseed supplementation 1–2 hours from medications. Omega-3 ALA and lignans may mildly enhance anticoagulant/antiplatelet effects; use caution with blood thinners. Some sources suggest caution with hormone-sensitive conditions due to phytoestrogen (lignan) content, though dietary amounts are unlikely to pose risk (Adolphe et al., 2010).
Pregnancy: Food amounts are generally considered safe; high-dose supplements should be discussed with a clinician due to limited safety data.
Duke (2002) rates flaxseed as +++ with clinical evidence (score 2) for antiatherogenic, hypocholesterolemic, laxative, lipolytic (fat-dissolving), and demulcent activities. Flaxseed's omega-3 fatty acids (ALA) and lignans are associated with reduced cardiovascular risk. Commission E approves flaxseed as a laxative and for mucilaginous protection of inflamed gastrointestinal mucosa. Dose: 1–2 tablespoons ground seed with ample water, twice daily. Whole seeds should be chewed or ground for full medicinal effect. Cyanogenic glycosides are present but at safe levels in normal dietary amounts (Duke, 2002).
Fenugreek appears https://www.nccih.nih.gov/health/fenugreek for most people.
Less serious side effects like diarrhea and indigestion have been reported anecdotally. You may also experience https://pubmed.ncbi.nlm.nih.gov/26251835/, which could be harmful if you have an eating disorder or are trying to https://www.healthline.com/nutrition/how-to-gain-weight. Moreover, some people report a strange and slightly sweet body odor when supplementing, but this is unconfirmed. Given its effect on blood sugar, fenugreek should be used with caution if you’re taking diabetes medication or other supplements that lower blood sugar levels.
Duke (2002) provides strong clinical evidence (score 2) for fenugreek's hypoglycemic and hypocholesterolemic activities — among the best-evidenced herbal treatments for blood sugar and lipid management. Anti-inflammatory and demulcent activities also have clinical support. The seed is Commission E approved as an appetite stimulant. Dose: 6–50 g of ground seeds daily for blood sugar management; 1–4 g seeds in tea for digestive use. The plant has lactagogue effects and can cause maple syrup-like body odor due to sotolon content. Contraindicated in pregnancy at medicinal doses due to uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Erect annual herb, slender and often branched near the top, growing 30-80 (up to 100) cm tall from a fine taproot. Leaves are alternate, sessile, narrowly lanceolate to linear, blue-green and entire-margined. Flowers are pale blue (occasionally white or pink), five-petalled and borne on slender stalks in loose terminal cymes. The fruit is a small globular capsule ('boll') that splits into ten compartments, each containing one flattened, glossy, red-brown seed.[5]
Erect annual herb with trifoliate leaves, each leaflet oblong and finely toothed toward the tip. Small, pale yellow to white, pea-like flowers are borne singly or in pairs in the leaf axils, followed by long, slender, curved seed pods.[11]
Habitat
Native to the Mediterranean region and the Fertile Crescent, cultivated since prehistory for fibre and oil and now grown worldwide in temperate regions with well-drained, fertile soils and a cool, moist growing season; occasionally found as a naturalised escape on waste and cultivated ground.[5]
Cultivated widely as a food and forage crop; native to the eastern Mediterranean and western Asia, now grown throughout South Asia, the Middle East and North Africa.[11]
Harvesting
Grown as an annual crop, seed is harvested once the capsules ('bolls') have dried and turned brown, typically in late summer, by cutting or combining the whole plant and threshing out the seed. Whole seed stores well; it should only be ground shortly before use, since the oil in ground seed oxidises and turns rancid quickly.[2]
Leaves and young sprouts are harvested throughout the growing season; seed pods are collected when fully mature and dried, then the hard seeds are threshed out.[11]
Traditional Uses
Flaxseed has a long history of traditional use as a bulk-forming laxative and demulcent for constipation and irritated gut mucosa, and as a poultice for boils and inflamed skin. Modern interest centres on its lignan (secoisolariciresinol diglucoside) and alpha-linolenic acid content, studied for cardiovascular, metabolic and hormone-related outcomes.[2, 4, 5]
Fenugreek seed has an ancient tradition across the Mediterranean, Middle East and South Asia as a digestive and appetite-stimulant remedy and lactation aid, and modern clinical research strongly supports its traditional use for blood sugar and cholesterol management, formalised in Commission E approval as an appetite stimulant.[5, 11, 12]
Preparations
Whole seed freshly ground (milled) and taken with plenty of liquid, or stirred into food; grinding is needed to make the oil and lignans bioavailable, as whole seeds largely pass through the gut undigested.
Cold-pressed oil taken as a concentrated source of alpha-linolenic acid (omega-3); lacks the fibre and lignan content of the whole ground seed.
Ground seeds taken with food, or whole seeds soaked/simmered as a tea, the traditional preparation for digestive and blood sugar support.
Standardized seed extract in capsule form, the form most used in clinical trials on blood sugar and cholesterol.
Dosage
Traditional guidance and Duke (2002) suggest 1-2 tablespoons of ground seed with ample water, once or twice daily. Educational reference only, not a prescription.
A randomised placebo-controlled trial titrated flax oil capsules (550 mg alpha-linolenic acid per 1 g of oil) to 12 capsules per day, i.e. up to roughly 12 g of oil daily, over 16 weeks - broadly matching the 1-2 tablespoons (about 10-15 mL) daily often cited for omega-3 intake. That trial was in children and adolescents with bipolar disorder and its primary outcomes were null; it is cited here only as a source for an administered human dose of the oil, not as evidence of benefit. Note the EU herbal monograph on Lini semen covers the SEED, not the oil. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Pairings
Not documented
Fenugreek and bitter melon can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 16]
Fenugreek and black seed (Nigella sativa) can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 17]
References & Sources
- Picur, B., Cebrat, M., Zabrocki, J. and Siemion, I.Z (2006) 'Cyclopeptides of Linum usitatissimum', Journal of Peptide Science, 12(9), pp. 569-574. doi:10.1002/psc.779 Preclinical
https://doi.org/10.1002/psc.779 - Basch, E., Bent, S., Collins, J., Dacey, C., Hammerness, P., Harrison, M., Smith, M., Szapary, P., Ulbricht, C., Vora, M. and Weissner, W (2007) 'Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration', Journal of the Society for Integrative Oncology, 5(3), pp. 92-105. doi:10.2310/7200.2007.005 Meta-analysis / review
https://doi.org/10.2310/7200.2007.005 - Chhillar, H., Chopra, P. and Ashfaq, M.A (2020) 'Lignans from linseed (Linum usitatissimum L.) and its allied species: retrospect, introspect and prospect', Critical Reviews in Food Science and Nutrition, 61(16), pp. 2719-2741. doi:10.1080/10408398.2020.1784840 Meta-analysis / review
https://doi.org/10.1080/10408398.2020.1784840 - Ansari, R., Zarshenas, M.M. and Dadbakhsh, A.H (2019) 'A review on pharmacological and clinical aspects of Linum usitatissimum L', Current Drug Discovery Technologies, 16(2), pp. 148-158. doi:10.2174/1570163815666180521101136 Meta-analysis / review
https://doi.org/10.2174/1570163815666180521101136 - Akter, Y., Junaid, M., Afrose, S.S., Nahrin, A., Alam, M.S., Sharmin, T., Akter, R. and Hosen, S.M.Z (2021) 'A comprehensive review on Linum usitatissimum medicinal plant: its phytochemistry, pharmacology, and ethnomedicinal uses', Mini Reviews in Medicinal Chemistry, 21(18), pp. 2801-2834. doi:10.2174/1389557521666210203153436 Meta-analysis / review
https://doi.org/10.2174/1389557521666210203153436 - Musazadeh, V., Abolghasemian, M., Kavyani, Z., Moridpour, A.H., Nazari, A. and Faghfouri, A.H (2024) 'The effects of flaxseed (Linum usitatissimum) supplementation on anthropometric indices: an updated systematic review and meta-analysis of randomized clinical trials', Complementary Therapies in Medicine, 84, pp. 103066. doi:10.1016/j.ctim.2024.103066 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2024.103066 - Mueed, A., Shibli, S., Jahangir, M., Jabbar, S. and Deng, Z (2022) 'A comprehensive review of flaxseed (Linum usitatissimum L.): health-affecting compounds, mechanism of toxicity, detoxification, anticancer and potential risk', Critical Reviews in Food Science and Nutrition, 63(32), pp. 11081-11104. doi:10.1080/10408398.2022.2092718 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2092718 - Kaithwas, G., Mukherjee, A., Chaurasia, A.K. and Majumdar, D.K (2011) 'Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil', Indian Journal of Experimental Biology, 49(12), pp. 932-938. Preclinical
https://scholar.google.com/scholar?q=Anti-inflammatory%2C%20analgesic%20and%20antipyretic%20activities%20of%20Linum%20usitatissimum%20L.%20%28flaxseed/linseed%29%20fixed%20oil - Rafieian-Kopaei, M., Shakiba, A., Sedighi, M. and Bahmani, M (2017) 'The analgesic and anti-inflammatory activity of Linum usitatissimum in Balb/c mice', Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), pp. 892-896. doi:10.1177/2156587217717416 Preclinical
https://doi.org/10.1177/2156587217717416 - Sirotkin, A.V (2023) 'Influence of flaxseed (Linum usitatissimum) on female reproduction', Planta Medica, 89(6), pp. 608-615. doi:10.1055/a-2013-2966 Meta-analysis / review
https://doi.org/10.1055/a-2013-2966 - Thompson, L.U., Chen, J.M., Li, T., Strasser-Weippl, K. and Goss, P.E (2006) 'Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer', 11(10), pp. 3828--3835. doi:10.1158/1078-0432.CCR-04-2326 Randomized trial
https://doi.org/10.1158/1078-0432.CCR-04-2326 - Adolphe, J.L., Whiting, S.J., Juurlink, B.H.J., Thorpe, L.U. and Alcorn, J (2010) 'Health effects with consumption of the flax lignan secoisolariciresinol diglucoside', 103(7), pp. 929--938. doi:10.1017/S0007114509992753 Clinical study
https://doi.org/10.1017/S0007114509992753 - Caligiuri, S.P.B., Edel, A.L., Aliani, M. and Pierce, G.N (2014) 'Flaxseed for hypertension: implications for improved cardiovascular risk', 16(12), pp. 499. doi:10.1007/s11906-014-0499-8 Randomized trial
https://doi.org/10.1007/s11906-014-0499-8 - European Food Safety Authority (2017) 'Safety of cyanogenic glycosides from flaxseed consumed as part of a usual diet', 15(11). doi:10.2903/j.efsa.2017.5026 Preclinical
https://doi.org/10.2903/j.efsa.2017.5026 - Harris, W.S (2012) 'Stearidonic acid as a surrogate for eicosapentaenoic acid in cardiovascular risk reduction: update and recommendation', 70(10), pp. 565--574. Traditional / reference
https://scholar.google.com/scholar?q=Stearidonic%20acid%20as%20a%20surrogate%20for%20eicosapentaenoic%20acid%20in%20cardiovascular%20risk%20reduction%3A%20update%20and%20recommendation - Latvijas valsts mežzinātnes institūts (n.d.) 'Linsēkla Latvijā'. Available at: https://www.silava.lv Traditional / reference
https://www.silava.lv - Pan, A., Sun, J., Chen, Y. et al (2009) 'Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial', 4(11). doi:10.1371/journal.pone.0007654 Randomized trial
https://doi.org/10.1371/journal.pone.0007654 - Royal Botanic Gardens, Kew (n.d.) 'Linum usitatissimum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:381313-1 - Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A. and Hibbeln, J.R (2010) 'Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder', Bipolar Disorders, 12(2), pp. 142-154. doi:10.1111/j.1399-5618.2010.00799.x Randomized trial
https://doi.org/10.1111/j.1399-5618.2010.00799.x - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Faghfoori, Z., Javadivala, Z., Khalili, Y. and Malek Mahdavi, A (2023) 'Effects of Trigonella foenum-graecum (fenugreek) on rheumatoid arthritis: a systematic review', Immunopharmacology and Immunotoxicology, 45(5), pp. 626-634. doi:10.1080/08923973.2023.2202298 Meta-analysis / review
https://doi.org/10.1080/08923973.2023.2202298 - Ouzir, M., El Bairi, K. and Amzazi, S (2016) 'Toxicological properties of fenugreek (Trigonella foenum graecum)', Food and Chemical Toxicology, 96, pp. 145-154. doi:10.1016/j.fct.2016.08.003 Meta-analysis / review
https://doi.org/10.1016/j.fct.2016.08.003 - Rao, A., Steels, E., Inder, W.J., Abraham, S. and others (2016) 'Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study', The Aging Male, 19(2), pp. 134-142. doi:10.3109/13685538.2015.1135323 Randomized trial
https://doi.org/10.3109/13685538.2015.1135323 - Avalos-Soriano, A., De la Cruz-Cordero, R., Rosado, J.L. and Garcia-Gasca, T (2016) '4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity', Molecules, 21(11), pp. 1596. doi:10.3390/molecules21111596 Preclinical
https://doi.org/10.3390/molecules21111596 - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', pp. 7. Meta-analysis / review
https://scholar.google.com/scholar?q=Effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20intake%20on%20glycemia%3A%20a%20meta-analysis%20of%20clinical%20trials - Nagulapalli Venkata, K.C., Swaroop, A., Bagchi, D. and Bishayee, A (2017) 'A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion', Molecular Nutrition & Food Research, 61(6), pp. 1600950. doi:10.1002/mnfr.201600950 Meta-analysis / review
https://doi.org/10.1002/mnfr.201600950 - Ulbricht, C., Basch, E., Burke, D., Cheung, L. and others (2007) 'Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration', Journal of Herbal Pharmacotherapy, 7(3-4), pp. 143-177. doi:10.1080/15228940802142852 Meta-analysis / review
https://doi.org/10.1080/15228940802142852 - El Bairi, K., Ouzir, M., Agnieszka, N. and Khalki, L (2017) 'Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets', Biomedicine & Pharmacotherapy, 90, pp. 479-491. doi:10.1016/j.biopha.2017.03.071 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2017.03.071 - Piao, C.H., Bui, T.T., Song, C.H., Shin, H.S. and others (2017) 'Trigonella foenum-graecum alleviates airway inflammation of allergic asthma in ovalbumin-induced mouse model', Biochemical and Biophysical Research Communications, 482(4), pp. 1284-1288. doi:10.1016/j.bbrc.2016.12.029 Preclinical
https://doi.org/10.1016/j.bbrc.2016.12.029 - Asif, M., Yousaf, H.M., Saleem, M., Saadullah, M. and others (2021) 'Trigonella foenum-graecum Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-alpha', Anti-Cancer Agents in Medicinal Chemistry, 21(11), pp. 1460-1471. doi:10.2174/1871520620666201005100132 Preclinical
https://doi.org/10.2174/1871520620666201005100132 - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Kumar, P. and Bhandari, U (2013) 'Protective effect of fenugreek (Trigonella foenum-graecum L.) seeds in experimentally-induced myocardial infarction', 23(2), pp. 255--261. Traditional / reference
https://scholar.google.com/scholar?q=Protective%20effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20seeds%20in%20experimentally-induced%20myocardial%20infarction - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', Nutrition Journal, 13, pp. 7. doi:10.1186/1475-2891-13-7 Meta-analysis / review
https://doi.org/10.1186/1475-2891-13-7 - Kim, J., Noh, W., Kim, A., Choi, Y. and Kim, Y.S (2023) 'The effect of fenugreek in type 2 diabetes and prediabetes: a systematic review and meta-analysis of randomized controlled trials', International Journal of Molecular Sciences, 24(18), pp. 13999. doi:10.3390/ijms241813999 Meta-analysis / review
https://doi.org/10.3390/ijms241813999 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.